logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Yiming Oncology-B (01541.HK) repurchased 92,400 shares for HK$297,600 on September 16.

date
16/09/2026
Zhitong Finance APP News, ImmuneOnco-B (01541.HK) announced that on September 16, 2026, the company spent HK$297,600 to repurchase 92,400 shares at a repurchase price of HK$3.155-3.27 per share.
Latest
2 m ago
New Stock News | DapuStor (301666.SZ) Said to Have Selected Investment Banks for Hong Kong Listing, Potentially IPO as Early as Next Year
2 m ago
Haitong Unitrust (01905.HK) plans to issue corporate bonds of no more than RMB 800 million.
3 m ago
JPMorgan reduces its holdings in Montage Technology (06809.HK) by approximately 208,203 shares at approximately HK$256.19 per share.
3 m ago
Mitsubishi UFJ Financial Group, Inc. increased its shareholding in Luxshare Precision (02475) by 756,200 shares at approximately HK$57 per share.
3 m ago
JPMorgan increases its shareholding in Angelalign (06699.HK) by approximately 168,100 shares at approximately HK$86.88 per share.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.